From Name:
From Email:
To Name:
To Email:

Optional Message:

5. Biosimilars: The Future of Pharma? An Interview With Boehringer Ingelheim

from European Pharmaceutical Review

From May 12: Biosimilars have the potential to deliver significant benefits to the healthcare community. These include, expanding overall treatment options and positively impacting the lives of patients suffering from life-threatening or chronic diseases, such as cancer or rheumatoid arthritis, whilst contributing to the quality and financial sustainability of healthcare systems. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063